Progressive
Care Inc. Issues Update
on Acquisition Process
MIAMI,
FL -- January
16,
2019 -- InvestorsHub NewsWire --
Progressive Care Inc. (OTCQB:
RXMD), a
personalized healthcare services and technology company,
today issued
an update regarding the pharmacy acquisition in process.
The
Company has completed due diligence and has executed a closing
extension for the purpose of finalizing the terms
of the purchase agreement, drafting necessary regulatory paperwork,
and completing final inventory counts.
"The
acquisition
process has run very smoothly," said S. Parikh Mars, CEO of
Progressive Care. "We believe that
acquisition will be
conducted in stages similar to that of PharmCo 1002, starting in
few weeks and completing in the second quarter of 2019. This
structure ensures that we will meet all
regulatory requirements of the relevant governing agencies.
We are excited to
continue in the process and make sure that the closing and
transition are executed properly."
For
more information about Progressive Care, please visit the
company'swebsite.
Connect and stay in touch with
us on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
About Progressive Care Inc.
Progressive Care
Inc. (OTCQB:
RXMD), through its PharmCo, LLC, is a South Florida health
services organization and provider of prescription pharmaceuticals,
compounded medications, provider of tele-pharmacy services, the
sale of anti-retroviral medications, medication therapy management
(MTM), the supply of prescription medications to long-term care
facilities, and health practice risk management.
Cautionary Statement Regarding Forward-Looking Statements
Statements contained herein that are not based upon current or
historical fact are forward-looking in nature and constitute
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934. Such forward-looking statements reflect the Company's
expectations about its future operating results, performance, and
opportunities that involve substantial risks and uncertainties.
These statements include but are not limited to statements
regarding the intended terms of the offering, closing of the
offering and use of any proceeds from the offering. When used
herein, the words "anticipate," "believe," "estimate," "upcoming,"
"plan," "target," "intend" and "expect" and similar expressions, as
they relate to Progressive Care Inc., its subsidiaries, or its
management, are intended to identify such forward-looking
statements. These forward-looking statements are based on
information
currently available to the Company and are subject to a number of
risks, uncertainties, and other factors that could cause the
Company's actual results, performance, prospects, and opportunities
to differ materially from those expressed in, or implied by, these
forward-looking statements.
Investor Relations Contact:
Armen
Karapetyan, Progressive Care
Senior Advisor
Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com
Public Relations Contact:
Kathleen
Gonzales, CMW
Media
Kathleen@cmwmedia.com
www.cmwmedia.com
Web and Application Development Contact:
Marcello Jaspan,
Mass Ventures Corp
Marcello@massventurescorp.com
www.massventurescorp.com